De novo MAP2K4 variants cause a novel neurodevelopmental syndrome with impaired JNK signaling in iPSC-derived neurons
Tomoki T. Nomakuchi, Alyssa L. Rippert, Sabrina A. Santos De Leon…·Elizabeth J. K. Bhoj
Author
Children's Hospital of PhiladelphiaORCID 0000-0001-7300-9311Unclaimed ORCID profile · follow to get notified of new preprints
5 papers
Recent·Most cited
Tomoki T. Nomakuchi, Alyssa L. Rippert, Sabrina A. Santos De Leon…·Elizabeth J. K. Bhoj
Anton Mikhailovich Safonov, Tomoki T. Nomakuchi, Elizabeth Chao…·Theodore G. Drivas
The paper identifies a higher prevalence of NF1 pathogenic variants using a genotype-first approach, finding many cases with somatic mosaicism and increased cancer risk.
Kelly J. Clark, Emily E. Lubin, Elizabeth M. Gonzalez…·Elizabeth J. K. Bhoj
NeuroTri2-VISDOT provides a web-based tool to explore second trimester human single-cell RNA sequencing data for Mendelian neurodevelopmental disorders, aiding in model system selection.
Luciano E. Marasco, Gwendal Dujardin, Rui Sousa‐Luís…·Alberto Rodolfo Kornblihtt
The paper shows that combining an ASO with HDAC inhibitors enhances SMN2 exon 7 inclusion in SMA mice, improving SMN expression and function.
Young Jin Kim, Tomoki T. Nomakuchi, Foteini Papaleonidopoulou…·Adrian R. Krainer
This study develops a cocktail of ASOs to specifically increase CFTR W1282X mRNA and protein levels by inhibiting NMD, improving chloride current in human bronchial epithelial cells.